Article
Chemoimmunotherapy for hairy cell leukemia.
Best practice & research. Clinical haematology - 1 Dec 2015
Ravandi Farhad
Abstract excerpt
Success in the treatment of patients with hairy cell leukemia (HCL) over the last several decades is largely due to the high efficacy of the nucleoside analogs, cladribine and pentostatin. However, the relapse-free survival curves have not shown a plateau and many patients treated with these agents will eventually relapse. Although better understanding of the pathogenic mechanisms in HCL have led to effective and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
